Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: A 6-year clinical and histological follow-up

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 1, 2009, Pages 58-66

  Christensen, E ^a   Skogvoll, E ^a   Viset, T ^a   Warloe, T ^b   Sundstrom S ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Basal cell carcinoma; Follow up studies; Histology; Photochemotherapy; Photodynamic therapy; Skin cancer

Indexed keywords

AMINOLEVULINIC ACID; DIMETHYL SULFOXIDE;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CURETTAGE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REMISSION; SKIN CARCINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; DIMETHYL SULFOXIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; REMISSION INDUCTION; SKIN NEOPLASMS;

EID: 57649230162     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02946.x     Document Type: Article

References (43)

1. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990 6 : 143 148.
2. Calzavara-Pinton PG, Venturini M, Sala R. Photodynamic therapy: update 2006. Part 2: Clinical results. J Eur Acad Dermatol Venereol 2007 21 : 439 451.
3. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 2002 147 : 41 47.
4. Staples M, Elwood M, Burton RC, Williams JL, Marks R, Graham GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006 184 : 6 10.
5. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994 30 : 774 778.
6. Peng Q, Warloe T, Berg K et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997 79 : 2282 2308.
7. Morton CA. Realizing the cosmetic potential of topical photodynamic therapy. J Cosmet Dermatol 2002 1 : 66 71.
8. Ahmadi S, McCarron PA, Donnelly RF, Woolfson AD, McKenna K. Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study. Exp Dermatol 2004 13 : 445 451.
9. Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000 142 : 338 339.
10. Warloe T, Heyerdahl H, Moan J, Steen HB, Giercksky K-E. Photodynamic therapy with 5-aminolaevulinic acid induced porphyrins and DMSO/EDTA for basal cell carcinoma. SPIE 1994 2371 : 226 235.
11. Haller JC, Cairnduff F, Slack G et al. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 2000 143 : 1270 1275.
12. Wang I, Bendsoe N, Klinteberg CA et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001 144 : 832 840.
13. Rook A, Wilkinson DS, Ebling FJG. Textbook of Dermatology, Vol. 4, Cap 78, 6th edn. Blackwell Science Ltd, Oxford, 1968.
14. Warloe T, Heyerdahl H, Gierchsky K-E. Curettage and topical ALA-based photodynamic therapy for nodular ulcerative basal cell carcinoma. Thesis. ISBN 82-7722-038-3, 1995; paper VI. University of Oslo.
15. Soler AM, Warloe T, Tausjo J, Berner A. Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Derm Venereol 1999 79 : 204 206.
16. Rhodes LE, de Rie M, Enstrom Y et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004 140 : 17 23.
17. Robinson JK, Rigel DS, Amonette RA. What promotes skin self-examination? J Am Acad Dermatol 1998 38 : 752 757.
18. Robinson JK, Fisher SG. Recurrent basal cell carcinoma after incomplete resection. Arch Dermatol 2000 136 : 1318 1324.
19. Horn M, Wolf P, Wulf HC, Warloe T et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003 149 : 1242 1249.
20. Vinciullo C, Elliott T, Francis D et al. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol 2005 152 : 765 772.
21. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B 1995 29 : 53 57.
22. Morton CA, MacKie RM, Whitehurst C, Moore JV, McColl JH. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol 1998 134 : 248 249.
23. Rubino C, Soggiu D, Farace F, Lissia M, Alfano C, Campus GV. Treatment of non-melanoma skin cancer in North Sardinia: is there a need for biopsy? Acta Chir Plast 2004 46 : 110 114.
24. Ek EW, Giorlando F, Su SY, Dieu T. Clinical diagnosis of skin tumours: how good are we? ANZ J Surg 2005 75 : 415 420.
25. Fink-Puches R, Soyer HP, Hofer A, Kerl H, Wolf P. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Arch Dermatol 1998 134 : 821 826.
26. R Developement Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna.
27. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989 15 : 315 328.
28. Braathen LR, Szeimies RM, Basset-Seguin N et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007 56 : 125 143.
29. Kuijpers DI, Thissen MR, Neumann MH. Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy. Am J Clin Dermatol 2002 3 : 247 259.
30. Swanson NA. Mohs surgery. Technique, indications, applications, and the future. Arch Dermatol 1983 119 : 761 773.
31. Ramachandran S, Fryer AA, Lovatt TJ et al. Combined effects of gender, skin type and polymorphic genes on clinical phenotype: use of rate of increase in numbers of basal cell carcinomas as a model system. Cancer Lett 2003 189 : 175 181.
32. Korbelik M. PDT-associated host response and its role in the therapy outcome. Lasers Surg Med 2006 38 : 500 508.
33. Rhodes LE, de Rie MA, Leifsdottir R et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 2007 143 : 1131 1136.
34. Rippey JJ. Why classify basal cell carcinomas? Histopathology 1998 32 : 393 398.
35. Varma S, Wilson H, Kurwa HA et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol 2001 144 : 567 574.
36. Morton CA, Brown SB, Collins S et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002 146 : 552 567.
37. Malik Z, Kostenich G, Roitman L, Ehrenberg B, Orenstein A. Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice. J Photochem Photobiol B 1995 28 : 213 218.
38. Peng Q, Warloe T, Moan J et al. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol 1995 62 : 906 913.
39. Moseley H, Brancaleon L, Lesar AE, Ferguson J, Ibbotson SH. Does surface preparation alter ALA uptake in superficial non-melanoma skin cancer in vivo? Photodermatol Photoimmunol Photomed 2008 24 : 72 75.
40. Saldanha G, Fletcher A, Slater DN. Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol 2003 148 : 195 202.
41. Peng Q, Soler AM, Warloe T, Nesland JM, Giercksky KE. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B 2001 62 : 140 145.
42. Kuijpers DI, Thissen MR, Thissen CA, Neumann MH. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. J Drugs Dermatol 2006 5 : 642 645.
43. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001 145 : 467 471.